Claritav (CTEV) Q1 2026: ACV Bookings Jump 44%, Pipeline Expansion Signals Durable Growth Trajectory
Claritav’s Q1 results spotlight a step-function increase in annual contract value bookings, with $44.1 million signed and a 70% YoY pipeline expansion fueling visibility into future growth. AI-driven operational leverage, new public sector and provider wins, and a sharpened focus on payment integrity have diversified revenue streams and fortified the company’s core. Management raised the revenue outlook floor, citing confidence in ACV conversion and a robust pipeline, but flagged a back-half weighted ramp as new bookings flow to revenue.
Summary
- ACV Bookings Surge: Record Q1 bookings and pipeline expansion drive confidence in multi-year targets.
- AI and Mix Shift: Operational leverage from AI and high-acuity claim focus underpin margin durability.
- Back-Half Ramp: Revenue growth expected to accelerate as new contracts convert in H2.
Business Overview
Claritav is a healthcare technology company providing data-driven software and services to payers, providers, and third-party administrators (TPAs). Its core offerings span claims intelligence, payment and revenue integrity, network analytics, and managed services, generating revenue through recurring SaaS contracts and value-based service fees. Major segments include its flagship claims intelligence platform, network services, payment integrity, and a growing managed services line targeting providers and public sector clients.
Performance Analysis
Claritav delivered another quarter of consistent growth, with revenue and adjusted EBITDA both exceeding internal expectations. The company’s $244.7 million in revenue represents a 5.8% YoY increase, with growth sourced from both core and expansion areas. Notably, flagship reference-based pricing solutions within claims intelligence grew 8.4% YoY, while network and payment revenue integrity also performed at or above plan.
Bookings momentum was the standout, with $44.1 million in annual contract value (ACV) signed in Q1—already nearly halfway to the full-year $80–100 million target. The pipeline expanded 70% YoY, and large deal activity accelerated, with nine deals over $1 million ACV closed (a 350% increase in seven-figure wins). Cross-sell and up-sell activity accounted for 73% of bookings, while 27% came from new clients, reflecting both core strength and diversification. Average deal sizes more than doubled, and sales cycle times compressed, supporting improved visibility and conversion rates.
- Mix Shift to High-Acuity Claims: Growth is increasingly driven by complex, higher-cost claims where Claritav’s solutions deliver greater savings, rather than pure volume expansion.
- AI-Driven Efficiency: Widespread AI adoption has nearly doubled coding team capacity and automated high-volume workflows, freeing resources and improving margin structure.
- Managed Services Traction: The acquisition of OPCG and new provider wins have established a recurring, high-value services business with attractive pull-through potential.
Cash flow dynamics reflected normal seasonality and the timing of interest payments, with Q1 a planned cash consumption quarter. Management reiterated that Q2 and Q4 will be cash-generating, and full-year free cash flow guidance remains positive.
Executive Commentary
"At the heart of that confidence is our competitive position, one that is grounded in our longstanding client relationships, scaled data ecosystem, deep domain expertise, and increasingly, our differentiated application of AI. In a market where accuracy, trust, and outcomes matter, those advantages are not easily replicated."
Travis Baldwin, President and Chief Executive Officer
"Our diversification strategy continues to be supported by strong sales momentum, highlighted by another record bookings quarter... Pipeline growth remained strong, increasing 70% year-over-year, alongside continuous improvements in lead qualification and sales execution."
Doug Garris, Chief Financial Officer
Strategic Positioning
1. ACV Bookings and Pipeline Visibility
The company’s record $44.1 million in Q1 bookings and a 70% YoY pipeline increase provide strong visibility into revenue growth over the next 12–18 months. Management highlighted improved sales execution, larger deal sizes, and higher win rates as drivers of this momentum. The current pipeline coverage to quota stands at 4.8x, supporting confidence in meeting or exceeding the $80–100 million ACV target.
2. AI-Enabled Operational Leverage
Claritav’s adoption of AI tools is delivering tangible operational leverage, nearly doubling coding capacity and automating high-volume, accuracy-sensitive workflows. This not only improves internal efficiency and margin durability, but also enhances the value proposition for clients in regulated, high-stakes healthcare environments.
3. Diversification Across Verticals
Expansion into the provider and public sector markets is yielding early wins, including a top-five health system and the World Trade Center Health Program. The managed services business, built on the OPCG acquisition, is driving new recurring revenue streams and enabling cross-sell of high-margin products.
4. Payment Integrity and TPA Market Focus
Payment and revenue integrity solutions remain a core growth engine, with 25–33% of pipeline opportunities in this area. The addition of an industry veteran to lead TPA market expansion signals a strategic push for deeper penetration in this segment, leveraging Claritav’s comprehensive platform and AI capabilities.
5. Margin Management and Investment Discipline
While investing aggressively to support new bookings and services ramp, management is threading the needle on margins, expecting stable or slightly improving EBITDA margins in the back half as ACV converts to revenue. The company is balancing near-term investment with a commitment to deleveraging and long-term cash flow growth.
Key Considerations
Claritav’s Q1 results reflect a company in transition from legacy claims volume to high-acuity, AI-driven, and service-diversified growth. Investors should weigh the following:
- Bookings-to-Revenue Conversion: New ACV typically takes 6–12 months to convert, creating a back-loaded revenue ramp and requiring patience for full P&L impact.
- Margin Profile of Services: Managed services bookings carry margins roughly half the core business at launch, but offer pull-through potential for higher-margin products over time.
- Volume vs. Mix Dynamics: Growth is driven by higher-value, complex claims rather than pure volume, increasing dependency on successful rate and mix management.
- AI Execution Risk: Continued margin expansion depends on sustained productivity gains and successful integration of AI across business lines.
Risks
Execution risk remains around the pace of ACV conversion and the ability to maintain margin discipline while scaling new service lines. The company’s growing exposure to managed services introduces lower initial margins and operational complexity. Regulatory shifts in healthcare reimbursement—such as changes to Medicare Advantage rules—could alter claims volumes or mix, though management currently sees limited direct impact. Competitive intensity in payment integrity and platform consolidation may pressure pricing or client retention if innovation lags.
Forward Outlook
For Q2 2026, Claritav guided to:
- Sequentially flat revenue as Q1 outperformance and last year’s one-time items normalize
- Stable adjusted EBITDA margins, with continued disciplined investment in growth
For full-year 2026, management raised revenue guidance to $985 million to $1 billion and maintained adjusted EBITDA guidance at $605–615 million (61–62% margin):
- 3%–5% revenue growth expected in H2 as ACV bookings convert
- Positive free cash flow and normalized cash conversion by year-end
Management noted:
- “We expect our growth rate to increase to between 3% to 5% for the second half of the year, adding up to the full-year guide.”
- “We are operating against vision 2030, not vision 20 minutes.”
Takeaways
Claritav’s Q1 demonstrated that the business is executing on its multi-year strategy, with bookings, pipeline, and operational leverage all moving in the right direction. Expansion into new verticals and services is diversifying the growth engine, but introduces new margin and execution considerations. Investors should focus on the pace of ACV conversion, margin trends as the mix shifts, and the durability of AI-driven efficiency gains.
- Bookings and Pipeline Strength: Record ACV and a robust pipeline support multi-year revenue visibility and investment confidence.
- Margin Durability and AI Leverage: AI adoption is driving productivity and margin resilience, but will require sustained execution to maintain its edge as the business scales.
- H2 Ramp and Service Mix: Revenue growth is weighted to the second half, with managed services and new verticals offering both opportunity and incremental risk.
Conclusion
Claritav’s Q1 results reinforce its position as a scaled, data-driven platform with expanding market reach and operational leverage. While new services and verticals are broadening the growth base, investors should monitor margin trends and ACV conversion as key forward indicators.
Industry Read-Through
Claritav’s results highlight a broader healthcare technology trend: platform consolidation, integrated data, and AI-driven automation are becoming critical for payers and providers seeking affordability and transparency. Incumbents with trusted data and compliance expertise are best positioned to capitalize on these shifts, as buyers increasingly seek fewer, more integrated partners. The shift to high-acuity, value-based claims and the rise of managed services suggest that pure volume-driven models are giving way to outcome-focused, technology-enabled platforms. Payment integrity and TPA markets remain attractive verticals for those with scale, domain expertise, and AI-enabled workflows.